QBTS Investment Check Before Q3 Earnings: Liquidity Solid Amid Risks

D-Wave Quantum (QBTS) has significantly improved its liquidity, holding $819.3 million in cash as of June 30, 2025, largely due to $675 million in equity financing rather than operational cash generation. Ahead of Q3 2025 earnings, which are projected to show 36.4% earnings and 66.8% revenue growth, the company continues to face operational losses and a highly stretched valuation, trading at a forward P/S of 387.37X. Despite a 381.6% YTD stock rally, analysts rate QBTS a "Sell" due to ongoing losses, dilution risk, and overvaluation, advising against new entry points.

Analysis

D-Wave Quantum (QBTS) significantly bolstered its balance sheet in the first half of 2025, reporting $819.3 million in cash and cash equivalents as of June 30, 2025, against minimal current liabilities of $19.3 million. This robust liquidity, providing a multi-quarter cash runway, was primarily driven by aggressive equity financing, including $675.0 million raised through ATM offerings and warrant exercises, rather than internal cash generation. This capital strength implies low near-term liquidity and solvency risk compared to the prior year.

Despite improved liquidity, operational performance remains mixed, with the company reporting $34.6 million in net cash used in operating activities during H1 2025 and continued GAAP losses, partly due to non-cash warrant revaluations. For Q3 2025, analysts anticipate substantial growth, projecting a 36.4% earnings improvement and 66.8% revenue growth, though the ability to limit dilution amid R&D spending and secure recurring revenues will be crucial.

QBTS shares have experienced a remarkable 381.6% year-to-date rally, significantly outperforming the S&P 500 and peers like IONQ and RGTI. However, the stock is currently deemed overvalued with a Value Score of F, trading at a forward 12-month Price/Sales ratio of 387.37X, which is substantially higher than its one-year median of 118.53X and the sector average of 6.62X. This suggests much of the optimism is already priced in.

The company faces ongoing challenges from operating losses, dilution risk, and a stretched valuation, leading to a Zacks Rank #4 (Sell) recommendation. Profitability remains distant, and sensitivity to non-cash swings continues to obscure true performance, indicating that the current price does not represent an ideal entry point for investors.

Key Decisions for Investors

• Given the stretched valuation, evidenced by a 387.37x forward P/S ratio and a Zacks #4 Sell rating, investors should exercise caution regarding new long positions in QBTS.
• Consider taking profits on existing positions, especially after the substantial 381.6% year-to-date rally, or await a more attractive valuation reset.
• Monitor Q3 earnings closely for signs of sustainable operational momentum, particularly recurring revenue growth and reduced cash burn, as equity financing alone is not a long-term solution for profitability.